Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. 4 Open-market sale Chief Financial Officer sold 20,000 shares at $36.17 ($723,400)
  2. 4 Open-market sale Chief Medical Officer sold 2,083 shares at $36.17 ($75,342)
  3. 4 Open-market sale Chief Business Development Off sold 6,771 shares at an average $41.30 ($279,648)
  4. 4 Open-market sale Chief Scientific Officer sold 33,300 shares at an average $42.84 ($1,426,698)
  5. 4 Open-market sale SVP and General Counsel sold 2,880 shares at an average $42.58 ($122,635)
  6. 8-K Event Other events
  7. 424B7 Offering Prospectus
  8. 4 Open-market sale Chief People Officer sold 2,000 shares at an average $39.36 ($78,725)
  9. 4 Open-market sale Chief Business Development Off sold 416 shares at $41.57 ($17,293)
  10. 4 Open-market sale Director sold 2,000 shares at an average $39.39 ($78,771)
  11. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $40.00 ($400,000)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale CEO and Chairman sold 41,035 shares at an average $37.42 ($1,535,408)
  15. 4 Open-market sale Chief Financial Officer sold 20,000 shares at $37.78 ($755,600)
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 4 Open-market sale Chief Medical Officer sold 6,250 shares at $40.00 ($250,000)
  19. 4 Open-market sale Chief Business Development Off sold 7,187 shares at $40.00 ($287,480)
  20. 4 Open-market sale EVP, Operations & Program Mana sold 1,600 shares at $37.37 ($59,792)

Page 32 of 42 · 837 filings